Li, Meng
Bristol-Myers Squibb (United States)
2 papers on CoChatORCID 0000-0002-8537-7872
Most cited papers
- Verified
Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study
Bal, S., Kocoglu, M. H., Nadeem, O., Htut, M., Gregory, T., Anderson, L. D., Costa, L. J., Buchholz, T. J., Ziyad, S., Li, M., et al. (2022) · Blood
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 38
- Verified
Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda
Li, M., Nyabigambo, A., Navvuga, P., Nuwamanya, E., Nuwasiima, A., Kaganda, P., Asiimwe, F. T., Vodicka, E., Mugisha, N. M., Mukose, A., et al. (2017) · Papillomavirus Research
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free